Graham K. Cooper - May 12, 2022 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Director
Signature
/s/ Marc Belsky, Attorney-in-Fact
Stock symbol
KZR
Transactions as of
May 12, 2022
Transactions value $
$0
Form type
4
Date filed
5/13/2022, 05:04 PM
Previous filing
Jan 31, 2022
Next filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Stock Option (right to buy) Award $0 +26K $0.00 26K May 12, 2022 Common Stock 26K $5.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth (1/36th) of the shares shall vest on a monthly basis commencing on May 12, 2022, subject to the Reporting Person continuing to provide service through each such date.